Literature DB >> 21450922

Understanding autoimmune uveitis through animal models. The Friedenwald Lecture.

Rachel R Caspi1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21450922      PMCID： PMC3101683          DOI： 10.1167/iovs.10-6909

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN： 0146-0404            Impact factor:   4.799


× No keyword cloud information.
  37 in total

1.  The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.

Authors:  P B Silver; C C Chan; B Wiggert; R R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-11       Impact factor: 4.799

2.  Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis.

Authors:  R K Agarwal; Y Kang; E Zambidis; D W Scott; C C Chan; R R Caspi
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 3.  A look at autoimmunity and inflammation in the eye.

Authors:  Rachel R Caspi
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

4.  Projection of an immunological self shadow within the thymus by the aire protein.

Authors:  Mark S Anderson; Emily S Venanzi; Ludger Klein; Zhibin Chen; Stuart P Berzins; Shannon J Turley; Harald von Boehmer; Roderick Bronson; Andrée Dierich; Christophe Benoist; Diane Mathis
Journal:  Science       Date:  2002-10-10       Impact factor: 47.728

5.  S antigen-induced experimental autoimmune uveo-retinitis in rats.

Authors:  Y de Kozak; J Sakai; B Thillaye; J P Faure
Journal:  Curr Eye Res       Date:  1981       Impact factor: 2.424

Review 6.  Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation.

Authors:  J Wayne Streilein
Journal:  J Leukoc Biol       Date:  2003-08       Impact factor: 4.962

Review 7.  Autoimmune uveitis and antigenic mimicry of environmental antigens.

Authors:  Gerhild Wildner; Maria Diedrichs-Möhring
Journal:  Autoimmun Rev       Date:  2004-07       Impact factor: 9.754

8.  A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice.

Authors:  Giuseppina Pennesi; Mary J Mattapallil; Shu-Hui Sun; Dody Avichezer; Phyllis B Silver; Zaruhi Karabekian; Chella S David; Paul A Hargrave; J Hugh McDowell; W Clay Smith; Barbara Wiggert; Larry A Donoso; Chi-Chao Chan; Rachel R Caspi
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

9.  Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study.

Authors:  David C Gritz; Ira G Wong
Journal:  Ophthalmology       Date:  2004-03       Impact factor: 12.079

10.  An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms.

Authors:  Dody Avichezer; Rafael S Grajewski; Chi-Chao Chan; Mary J Mattapallil; Phyllis B Silver; James A Raber; Gregory I Liou; Barbara Wiggert; Giavonni M Lewis; Larry A Donoso; Rachel R Caspi
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307
View more
  29 in total

Review 1.  Interplay between innate and adaptive immunity in the development of non-infectious uveitis.

Authors:  François Willermain; James T Rosenbaum; Bahram Bodaghi; Holly L Rosenzweig; Sarah Childers; Travis Behrend; Gerhild Wildner; Andrew D Dick
Journal:  Prog Retin Eye Res       Date:  2011-11-22       Impact factor: 21.198

2.  IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.

Authors:  Reiko Horai; Mary J Mattapallil; Wai Po Chong; Phyllis B Silver; Jun Chen; Ru Zhou; Yuri Sergeev; Rafael Villasmil; Chi-Chao Chan; Rachel R Caspi
Journal:  J Autoimmun       Date:  2013-09-07       Impact factor: 7.094

3.  The Effect of Different Dosing Schedules of Intravitreal Sirolimus, a Mammalian Target of Rapamycin (mTOR) Inhibitor, in the Treatment of Non-Infectious Uveitis (An American Ophthalmological Society Thesis).

Authors:  Quan Dong Nguyen; Mohammad Ali Sadiq; Mohamed Kamel Soliman; Aniruddha Agarwal; Diana V Do; Yasir J Sepah
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

Review 4.  Ocular diseases: immunological and molecular mechanisms.

Authors:  Jing Song; Yi-Fei Huang; Wen-Jing Zhang; Xiao-Fei Chen; Yu-Mian Guo
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

5.  Alemtuzumab-induced remission of multiple sclerosis-associated uveitis.

Authors:  Mark D Willis; Trevor P Pickersgill; Neil P Robertson; Richard W J Lee; Andrew D Dick; Ester Carreño
Journal:  Int Ophthalmol       Date:  2016-10-11       Impact factor: 2.031

Review 6.  Interleukin 35-Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases.

Authors:  Charles E Egwuagu; Cheng-Rong Yu
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

Review 7.  Statins as anti-inflammatory agents: A potential therapeutic role in sight-threatening non-infectious uveitis.

Authors:  Rose Gilbert; Ahmed Al-Janabi; Oren Tomkins-Netzer; Sue Lightman
Journal:  Porto Biomed J       Date:  2017-03-01

Review 8.  Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation.

Authors:  R W J Lee; A D Dick
Journal:  Eye (Lond)       Date:  2011-09-30       Impact factor: 3.775

9.  Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells.

Authors:  Ren-Xi Wang; Cheng-Rong Yu; Rashid M Mahdi; Charles E Egwuagu
Journal:  J Biol Chem       Date:  2012-08-30       Impact factor: 5.157

10.  Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis.

Authors:  Chang He; Cheng-Rong Yu; Lin Sun; Rashid M Mahdi; Joseph Larkin; Charles E Egwuagu
Journal:  J Autoimmun       Date:  2015-06-19       Impact factor: 7.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.